Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
412,914,375
-
Total 13F shares
-
3,085,723
-
Share change
-
+208,731
-
Total reported value
-
$58,690,000
-
Price per share
-
$19.02
-
Number of holders
-
11
-
Value change
-
+$1,761,108
-
Number of buys
-
7
-
Number of sells
-
8
Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q2 2021
As of 30 Jun 2021,
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,085,723 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Ikarian Capital, LLC, MARSHALL WACE, LLP, BOOTHBAY FUND MANAGEMENT, LLC, Marshall Wace North America L.P., MEITAV DASH INVESTMENTS LTD, Virtu Financial LLC, Spire Wealth Management, MORGAN STANLEY, and UBS Group AG.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.